Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients
Clinical trial NCT02091531 · COMPLETED
Trial details
- NCT number
- NCT02091531
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2018-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.